rs751396065

Variant summary

Our verdict is Likely benign.
-2 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -2 classification points (ACMG Germline Pathogenicity v2019). PM2BP4_Strong

The NM_002227.4(JAK1):c.3369+4T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

JAK1
NM_002227.4 splice_region, intron

Scores

3
Splicing: ADA: 0.0002228
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.505

Publications

0 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002227.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -2 points.

PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate.
BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002227.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

JAK1 NM_002227.4
MANE Select
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 24 of 24
splice_regionintron
Prot: NP_002218.2UniProt: P23458
JAK1 NM_001320923.2
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 25 of 25
splice_regionintron
Prot: NP_001307852.1UniProt: P23458
JAK1 NM_001321852.2
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 24 of 24
splice_regionintron
Prot: NP_001308781.1UniProt: P23458

Ensembl Transcripts

JAK1 ENST00000342505.5
TSL:5MANE Select
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 24 of 24
splice_regionintron
Prot: ENSP00000343204.4UniProt: P23458
JAK1 ENST00000671929.2
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 25 of 25
splice_regionintron
Prot: ENSP00000500485.1UniProt: P23458
JAK1 ENST00000671954.2
HGVSc / HGVSpc.3369+4T>G
Exon rankIntron 25 of 25
splice_regionintron
Prot: ENSP00000500841.1UniProt: P23458

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:22
GnomAD4 genome
Cov:33
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)

Computational Scores

AlphaGenome AVI
Benign1.2
BayesDel_noAF
Benign-0.82
CADD
Benign3.8
DANN
Benign0.73
GPN-Star LLR
N/A-3.5
GPN-Star score
N/A3.5
PhyloP100
Benign-0.51
Showing 7 of 7 scores

Splicing Scores

dbscSNV1_ADA
Benign0.00022
dbscSNV1_RF
Benign0.036
Pangolin (max)
Benign0.11
Pangolin loss
Benign0.11
Position offset: 4
SpliceAI score (max)
Benign0.11
Details are displayed if max score is > 0.2
Showing 5 of 5 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.